Elixirr Announces Director/PDMR Shareholding
The consulting firm announces a director's family member has purchased shares in the company.
The consulting firm announces a director's family member has purchased shares in the company.
The consulting firm reported stellar H1 results, with revenue up 35% and adjusted EBITDA soaring 42%. Strong organic growth and strategic acquisitions position it well for continued success.
The consulting firm acquires US-based TRC Advisory, a specialist in growth strategy and commercial effectiveness, in a deal expected to be immediately accretive to earnings.
The consulting firm has secured an increase in its revolving credit facility and a new term loan to support its organic and inorganic growth strategy.
The consulting firm is hosting an investor presentation to discuss its H1 2025 results.
The consulting firm is transitioning its shares to the SETS trading platform on the London Stock Exchange, providing investors with improved liquidity.
The consulting firm reports a 35% increase in total revenue and a 17% rise in organic revenue for the first half of 2025, maintaining consistent profitability margins.
The consulting firm has appointed a new corporate broker, Cavendish Capital Markets, to work with the company.
The consulting firm has granted share options to two of its top executives as part of their long-term incentive plans.
The consulting firm plans to move its listing from the AIM market to the Main Market of the London Stock Exchange, a natural step in its evolution as a high-growth listed business.